Physician profile
Robert Siska
NPI 1396278552
$926.12
in general payments reported to CMS, 2019-2025
9 companies · $16.16 in 2025
The $16.16 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $244 · 2024: $666 · 2025: $16.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $213.49 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $165.79 | 2024 | |
| Rti Surgical, INC | $139.65 | 2024 | |
| Avita Medical Americas, LLC | $133.85 | 2023 | Recell |
| Innovation Technologies INC | $110.49 | 2023 | Irrisept |
| Abbvie INC. | $93.29 | 2024 | |
| Tela Bio, INC. | $25.44 | 2024 | Ovitex 2s |
| Solventum Corporation | $23.74 | 2024 | Activ.A.C. Ion Progress, Snap, V.A.C. Veraflo |
| Mentor Worldwide LLC | $20.38 | 2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Siska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.